NAP prevents acute cerebral oxidative stress and protects against long-term brain injury and cognitive impairment in a model of neonatal hypoxia-ischemia

Neurobiology of Disease

Volumn 44, Issue 1, 2011, Pages 152-159

  Greggio, Samuel ^a   de Paula, Simone ^a   de Oliveira, Iuri M ^b   Trindade, Cristiano ^b   Rosa, Renato M ^c   Henriques, João A P ^b   DaCosta, Jaderson C ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Brain lesion; Memory; NAP; Neuroprotection; Oxidative stress; Perinatal hypoxia ischemia; Rat model

Indexed keywords

DAVUNETIDE; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN SIZE; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LEARNING; LIPID PEROXIDATION; MAZE TEST; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SPATIAL MEMORY; TASK PERFORMANCE;

ANIMALS; ANIMALS, NEWBORN; CEREBRAL CORTEX; COGNITION DISORDERS; COMET ASSAY; DNA DAMAGE; FEMALE; FUNCTIONAL LATERALITY; GLUTATHIONE; HIPPOCAMPUS; HYPOXIA-ISCHEMIA, BRAIN; LIPID PEROXIDATION; MAZE LEARNING; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY; RATS; RATS, WISTAR;

EID: 79960976322     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.06.018     Document Type: Article

References (60)

1. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981, 77:373-382.
2. Alcalay R.N., Giladi E., Pick C.G., Gozes I. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze. Neurosci. Lett. 2004, 361:128-131.
3. Alles Y.C., Greggio S., Alles R.M., Azevedo P.N., Xavier L.L., Dacosta J.C. A novel preclinical rodent model of collagenase-induced germinal matrix/intraventricular hemorrhage. Brain Res. 2010, 1356:130-138.
4. Ashur-Fabian O., Giladi E., Furman S., Steingart R.A., Wollman Y., Fridkin M., Brenneman D.E., Gozes I. Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures. Neurosci. Lett. 2001, 307:167-170.
5. Bagenholm R., Nilsson U.A., Kjellmer I. Formation of free radicals in hypoxic ischemic brain damage in the neonatal rat, assessed by an endogenous spin trap and lipid peroxidation. Brain Res. 1997, 773:132-138.
6. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D.E., Gozes I. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 1999, 72:1283-1293.
7. Beni-Adani L., Gozes I., Cohen Y., Assaf Y., Steingart R.A., Brenneman D.E., Eizenberg O., Trembolver V., Shohami E. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 2001, 296:57-63.
8. Brenneman D.E., Spong C.Y., Hauser J.M., Abebe D., Pinhasov A., Golian T., Gozes I. Protective peptides that are orally active and mechanistically nonchiral. J. Pharmacol. Exp. Ther. 2004, 309:1190-1197.
9. Buonocore G., Perrone S., Bracci R. Free radicals and brain damage in the newborn. Biol. Neonate 2001, 79:180-186.
10. Burlinson B., Tice R.R., Speit G., Agurell E., Brendler-Schwaab S.Y., Collins A.R., Escobar P., Honma M., Kumaravel T.S., Nakajima M., Sasaki Y.F., Thybaud V., Uno Y., Vasquez M., Hartmann A. Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat. Res. 2007, 627:31-35.
11. Busciglio J., Pelsman A., Helguera P., Ashur-Fabian O., Pinhasov A., Brenneman D.E., Gozes I. NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis. Curr. Pharm. Des. 2007, 13:1091-1098.
12. Cai J., Kang Z., Liu K., Liu W., Li R., Zhang J.H., Luo X., Sun X. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009, 1256:129-137.
13. Chen S., Charness M.E. Ethanol inhibits neuronal differentiation by disrupting activity-dependent neuroprotective protein signaling. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19962-19967.
14. Dafre A.L., Arteni N.S., Siqueira I.R., Netto C.A. Perturbations in the thiol homeostasis following neonatal cerebral hypoxia-ischemia in rats. Neurosci. Lett. 2003, 345:65-68.
15. de Paula S., Vitola A.S., Greggio S., de Paula D., Mello P.B., Lubianca J.M., Xavier L.L., Fiori H.H., Dacosta J.C. Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells. Pediatr. Res. 2009, 65:631-635.
16. Ferriero D.M. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev. Neurosci. 2001, 23:198-202.
17. Goldberg S., Visochek L., Giladi E., Gozes I., Cohen-Armon M. PolyADP-ribosylation is required for long-term memory formation in mammals. J. Neurochem. 2009, 111:72-79.
18. Gozes I., Alcalay R., Giladi E., Pinhasov A., Furman S., Brenneman D.E. NAP accelerates the performance of normal rats in the water maze. J. Mol. Neurosci. 2002, 19:167-170.
19. Gozes I., Steingart R.A., Spier A.D. NAP mechanisms of neuroprotection. J. Mol. Neurosci. 2004, 24:67-72.
20. Gozes I., Morimoto B.H., Tiong J., Fox A., Sutherland K., Dangoor D., Holser-Cochav M., Vered K., Newton P., Aisen P.S., Matsuoka Y., van Dyck C.H., Thal L. NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). CNS Drug Rev. 2005, 11:353-368.
21. Greggio S., Rosa R.M., Dolganov A., de Oliveira I.M., Menegat F.D., Henriques J.A., Dacosta J.C. NAP prevents hippocampal oxidative damage in neonatal rats subjected to hypoxia-induced seizures. Neurobiol. Dis. 2009, 36:435-444.
22. Gundersen H.J., Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 1987, 147:229-263.
23. Incerti M., Vink J., Roberson R., Wood L., Abebe D., Spong C.Y. Reversal of alcohol-induced learning deficits in the young adult in a model of fetal alcohol syndrome. Obstet. Gynecol. 2010, 115:350-356.
24. Incerti M., Toso L., Vink J., Roberson R., Nold C., Abebe D., Spong C.Y. Prevention of learning deficit in a Down syndrome model. Obstet. Gynecol. 2011, 117:354-361.
25. Kumar A., Mittal R., Khanna H.D., Basu S. Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics 2008, 122:e722-e727.
26. Kumral A., Yesilirmak D.C., Sonmez U., Baskin H., Tugyan K., Yilmaz O., Genc S., Gokmen N., Genc K., Duman N., Ozkan H. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats. Brain Res. 2006, 1115:169-178.
27. Lafemina M.J., Sheldon R.A., Ferriero D.M. Acute hypoxia-ischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr. Res. 2006, 59:680-683.
28. Leker R.R., Teichner A., Grigoriadis N., Ovadia H., Brenneman D.E., Fridkin M., Giladi E., Romano J., Gozes I. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 2002, 33:1085-1092.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
30. Nadin S.B., Vargas-Roig L.M., Ciocca D.R. A silver staining method for single-cell gel assay. J. Histochem. Cytochem. 2001, 49:1183-1186.
31. Nagayama T., Simon R.P., Chen D., Henshall D.C., Pei W., Stetler R.A., Chen J. Activation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia. J. Neurochem. 2000, 74:1636-1645.
32. Offen D., Sherki Y., Melamed E., Fridkin M., Brenneman D.E., Gozes I. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res. 2000, 854:257-262.
33. Pascual M., Guerri C. The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol. J. Neurochem. 2007, 103:557-568.
34. Perlman J.M. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin. Ther. 2006, 28:1353-1365.
35. Rice J.E., Vannucci R.C., Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 1981, 9:131-141.
36. Rotstein M., Bassan H., Kariv N., Speiser Z., Harel S., Gozes I. NAP enhances neurodevelopment of newborn apolipoprotein E-deficient mice subjected to hypoxia. J. Pharmacol. Exp. Ther. 2006, 319:332-339.
37. Salgo M.G., Pryor W.A. Trolox inhibits peroxynitrite-mediated oxidative stress and apoptosis in rat thymocytes. Arch. Biochem. Biophys. 1996, 333:482-488.
38. Satchell M.A., Zhang X., Kochanek P.M., Dixon C.E., Jenkins L.W., Melick J., Szabo C., Clark R.S. A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14-3-3gamma. J. Neurochem. 2003, 85:697-708.
39. Schmidt H., Grune T., Muller R., Siems W.G., Wauer R.R. Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia. Pediatr. Res. 1996, 40:15-20.
40. Sheldon R.A., Aminoff A., Lee C.L., Christen S., Ferriero D.M. Hypoxic preconditioning reverses protection after neonatal hypoxia-ischemia in glutathione peroxidase transgenic murine brain. Pediatr. Res. 2007, 61:666-670.
41. Shi Y., Pan F., Li H., Pan J., Qin S., Shen C. Role of carbon monoxide and nitric oxide in newborn infants with postasphyxial hypoxic-ischemic encephalopathy. Pediatrics 2000, 106:1447-1451.
42. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
43. Sokolowska P., Passemard S., Mok A., Schwendimann L., Gozes I., Gressens P. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy. Neuroscience 2011, 173:156-168.
44. Spong C.Y., Abebe D.T., Gozes I., Brenneman D.E., Hill J.M. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J. Pharmacol. Exp. Ther. 2001, 297:774-779.
45. Steingart R.A., Gozes I. Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress. Mol. Cell. Endocrinol. 2006, 252:148-153.
46. Steingart R.A., Solomon B., Brenneman D.E., Fridkin M., Gozes I. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J. Mol. Neurosci. 2000, 15:137-145.
47. Takizawa Y., Miyazawa T., Nonoyama S., Goto Y., Itoh M. Edaravone inhibits DNA peroxidation and neuronal cell death in neonatal hypoxic-ischemic encephalopathy model rat. Pediatr. Res. 2009, 65:636-641.
48. Toso L., Endres M., Vink J., Abebe D.T., Brenneman D.E., Spong C.Y. Learning enhancement with neuropeptides. Am. J. Obstet. Gynecol. 2006, 194:1153-1158. discussion 1158-9.
49. Toso L., Poggi S.H., Roberson R., Woodard J., Park J., Abebe D., Spong C.Y. Prevention of alcohol-induced learning deficits in fetal alcohol syndrome mediated through NMDA and GABA receptors. Am. J. Obstet. Gynecol. 2006, 194:681-686.
50. Toso L., Johnson A., Bissell S., Roberson R., Abebe D., Spong C.Y. Understanding the mechanism of learning enhancement: NMDA and GABA receptor expression. Am. J. Obstet. Gynecol. 2007, 197:267.e1-267.e4.
51. Toso L., Roberson R., Abebe D., Spong C.Y. Neuroprotective peptides prevent some alcohol-induced alteration in gamma-aminobutyric acid A-beta3, which plays a role in cleft lip and palate and learning in fetal alcohol syndrome. Am. J. Obstet. Gynecol. 2007, 196:259.e1-259.e5.
52. Venturin, G.T., et al., in press. Bone marrow mononuclear cells reduce seizure frequency and improve cognitive outcome in chronic epileptic rats. Life Sci. doi:10.1016/j.lfs.2011.06.006.
53. Vink J., Auth J., Abebe D.T., Brenneman D.E., Spong C.Y. Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome. Am. J. Obstet. Gynecol. 2005, 193:825-829.
54. Vink J., Incerti M., Toso L., Roberson R., Abebe D., Spong C.Y. Prenatal NAP+SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-d-aspartic acid and gamma-aminobutyric acid receptors. Am. J. Obstet. Gynecol. 2009, 200:524.e1-524.e4.
55. Visochek L., Steingart R.A., Vulih-Shultzman I., Klein R., Priel E., Gozes I., Cohen-Armon M. PolyADP-ribosylation is involved in neurotrophic activity. J. Neurosci. 2005, 25:7420-7428.
56. Volpe J.J. Hypoxic-Ischemic Encephalopathy: Clinical Aspects. Neurology of the Newborn 2008, 400-480. Saunders, Philadelphia.
57. Vulih-Shultzman I., Pinhasov A., Mandel S., Grigoriadis N., Touloumi O., Pittel Z., Gozes I. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J. Pharmacol. Exp. Ther. 2007, 323:438-449.
58. Weis S.N., Schunck R.V., Pettenuzzo L.F., Krolow R., Matte C., Manfredini V., Peralba M.D., Vargas C.R., Dalmaz C., Wyse A.T., Netto C.A. Early biochemical effects after unilateral hypoxia-ischemia in the immature rat brain. Int. J. Dev. Neurosci. 2011.
59. Zaltzman R., Alexandrovich A., Beni S.M., Trembovler V., Shohami E., Gozes I. Brain injury-dependent expression of activity-dependent neuroprotective protein. J. Mol. Neurosci. 2004, 24:181-187.
60. Zhu C., Wang X., Hagberg H., Blomgren K. Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia. J. Neurochem. 2000, 75:819-829.